Regado Biosciences

Tobira pulls off a $40M Wall Street end-around with sights set on NASH
Fierce Biotech
Tue, 05/5/15 - 09:41 am
Tobira Pharmaceuticals
NASH
Regado Biosciences
Biotech Weekly: The Failed Biotech Life Cycle And The Regado-Tobira Merger
Seeking Alpha
Tue, 01/20/15 - 09:28 am
Regado Biosciences
M&A
Tobira Pharmaceuticals
The Worst-Performing Biotech Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:36 pm
biotech
Nymox
Elbit
PhotoMedex
Sophiris Bio
WaferGen Bio-systems
Nanosphere
Cyclacel
MELA Sciences
Cytori
Regado Biosciences
BioLife Solutions
Regado permanantly halts enrollment in lead drug trial
Yahoo/AP
Mon, 08/25/14 - 08:27 am
Regado Biosciences
clinical trials
Revolixys
bloodthinners
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Forbes
Thu, 07/10/14 - 03:42 pm
FDA
Regado Biosciences
anticoagulants
Revolixys
Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisition Deal
Yahoo/Zacks.com
Wed, 07/9/14 - 09:26 am
Regado Biosciences
Jazz Pharmaceuticals
Regeneron
Sanofi
blinatumomab
Amgen
Defitelio
Regado Halts Big Heart Drug Trial, Shares Hammered
Motley Fool
Thu, 07/3/14 - 10:37 am
Regado Biosciences
clinical trials
REG1
anticoagulants
2 Small Biotech Plays Moving Up On Positive News
Seeking Alpha
Wed, 06/11/14 - 05:33 pm
Regado Biosciences
Navidea Biopharmaceuticals
Regado Biosciences' REG2 investigational new drug application accepted by FDA
Yahoo/Fly on the Wall
Thu, 02/13/14 - 09:14 am
Regado Biosciences
REG2
subacute venous thrombosis
Regado misses IPO fiesta, limps into public spotlight with $43M raise
Fierce Biotech
Thu, 08/22/13 - 10:08 am
IPOs
Regado Biosciences
[video] Drugs IPOs Depend on Deals
TheStreet.com
Tue, 06/18/13 - 10:00 am
IPOs
Patient Care Technologies
Celgene
Bluebird Bio
Roche
Regado Biosciences